Balansag, Analyn .

HRN: 13-13-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2024
AMPICILLIN 1GM (VIAL)
10/14/2024
10/16/2024
IVT
2gm
Q6
PROM
Waiting Final Action 
10/14/2024
CEFUROXIME 500MG (TAB)
10/14/2024
10/21/2024
ORAL
500mg
BID
Thinly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: